Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arndt Hartmann

Showing results (171-180 of 975) with videos related to

Pageof 98
Sort By:
Oncology Reports|March 29, 2007
p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohortAnnette Pantelis, Dimitrios Pantelis, Petra Ruemmele, et al.
JCO Precision Oncology|January 20, 2022
Successful Targeting of <i>BRAF</i> V600E Mutation With Vemurafenib in a Treatment-Resistant Extragonadal Nonseminomatous Germ-Cell TumorLisa Meintker, Florian Haller, Lars Tögel, et al.
Scientific Reports|April 18, 2020
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinomaMichael Friedrich, Nadine Heimer, Christine Stoehr, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2002
Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clonesRobert Stoehr, Ruth Knuechel, Joerg Boecker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2002
Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysisHagen Blaszyk, Linan Wang, Wolfgang Dietmaier, et al.
BMC Cancer|July 3, 2009
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerJürgen Veeck, Peter J Wild, Thomas Fuchs, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 13, 2013
Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancerFlorian Hitzenbichler, Christine G Stoehr, Michael Rogenhofer, et al.
BMC Urology|May 11, 2023
Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinomaMaximilian Erlmeier, Marie Mikuteit, Stefanie Zschäbitz, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 25, 2007
Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patientsStefan Denzinger, Wolfgang Otto, Hans-Martin Fritsche, et al.
Plos One|July 19, 2014
BDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression?Laura Huth, Michael Rose, Veronika Kloubert, et al.
Pageof 98

Showing results (171-180 of 975) with videos related to

Sort By:
Pageof 98
Oncology Reports|March 29, 2007
p53 Codon 72 polymorphism, loss of heterozygosity and high-risk human papillomavirus infection in a low-incidence German esophageal squamous cell carcinoma patient cohortAnnette Pantelis, Dimitrios Pantelis, Petra Ruemmele, et al.
JCO Precision Oncology|January 20, 2022
Successful Targeting of <i>BRAF</i> V600E Mutation With Vemurafenib in a Treatment-Resistant Extragonadal Nonseminomatous Germ-Cell TumorLisa Meintker, Florian Haller, Lars Tögel, et al.
Scientific Reports|April 18, 2020
CREB1 is affected by the microRNAs miR-22-3p, miR-26a-5p, miR-27a-3p, and miR-221-3p and correlates with adverse clinicopathological features in renal cell carcinomaMichael Friedrich, Nadine Heimer, Christine Stoehr, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2002
Histologic-genetic mapping by allele-specific PCR reveals intraurothelial spread of p53 mutant tumor clonesRobert Stoehr, Ruth Knuechel, Joerg Boecker, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 16, 2002
Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysisHagen Blaszyk, Linan Wang, Wolfgang Dietmaier, et al.
BMC Cancer|July 3, 2009
Prognostic relevance of Wnt-inhibitory factor-1 (WIF1) and Dickkopf-3 (DKK3) promoter methylation in human breast cancerJürgen Veeck, Peter J Wild, Thomas Fuchs, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|November 13, 2013
Mdm2 SNP309 G-variant is associated with invasive growth of human urinary bladder cancerFlorian Hitzenbichler, Christine G Stoehr, Michael Rogenhofer, et al.
BMC Urology|May 11, 2023
Immunohistochemical expression of the hepatocyte growth factor in chromophobe renal cell carcinomaMaximilian Erlmeier, Marie Mikuteit, Stefanie Zschäbitz, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|October 25, 2007
Bladder sparing approach for initial T1G3 bladder cancer: Do multifocality, size of tumor or concomitant carcinoma in situ matter? A long-term analysis of 132 patientsStefan Denzinger, Wolfgang Otto, Hans-Martin Fritsche, et al.
Plos One|July 19, 2014
BDNF is associated with SFRP1 expression in luminal and basal-like breast cancer cell lines and primary breast cancer tissues: a novel role in tumor suppression?Laura Huth, Michael Rose, Veronika Kloubert, et al.
Pageof 98